Pacira Biosciences, Inc. (PCRX)
25.31
+0.45
(+1.81%)
USD |
NASDAQ |
Aug 25, 14:32
Pacira Biosciences EPS Diluted (Quarterly) : 0.1155 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1155 |
| March 31, 2026 | 0.0713 |
| December 31, 2025 | 0.0381 |
| September 30, 2025 | 0.1222 |
| June 30, 2025 | -0.1066 |
| March 31, 2025 | 0.1034 |
| December 31, 2024 | 0.3271 |
| September 30, 2024 | -3.110 |
| June 30, 2024 | 0.3888 |
| March 31, 2024 | 0.1918 |
| December 31, 2023 | 0.4777 |
| September 30, 2023 | 0.2283 |
| June 30, 2023 | 0.4949 |
| March 31, 2023 | -0.4252 |
| December 31, 2022 | -0.2202 |
| September 30, 2022 | -0.0151 |
| June 30, 2022 | 0.3787 |
| March 31, 2022 | 0.147 |
| December 31, 2021 | -0.115 |
| September 30, 2021 | 0.3884 |
| June 30, 2021 | 0.4185 |
| March 31, 2021 | 0.2256 |
| December 31, 2020 | 0.3245 |
| September 30, 2020 | 2.939 |
| June 30, 2020 | -0.1722 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1907 |
| December 31, 2019 | -0.117 |
| September 30, 2019 | -0.1462 |
| June 30, 2019 | 0.0645 |
| March 31, 2019 | -0.0672 |
| December 31, 2018 | 0.1962 |
| September 30, 2018 | -0.0156 |
| June 30, 2018 | 0.0615 |
| March 31, 2018 | -0.2624 |
| December 31, 2017 | 0.11 |
| September 30, 2017 | -0.19 |
| June 30, 2017 | -0.49 |
| March 31, 2017 | -0.52 |
| December 31, 2016 | -0.11 |
| September 30, 2016 | -0.59 |
| June 30, 2016 | -0.21 |
| March 31, 2016 | -0.10 |
| December 31, 2015 | -0.07 |
| September 30, 2015 | 0.0752 |
| June 30, 2015 | 0.0002 |
| March 31, 2015 | 0.03 |
| December 31, 2014 | 0.14 |
| September 30, 2014 | -0.08 |
| June 30, 2014 | -0.14 |
| March 31, 2014 | -0.34 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zimmer Biomet Holdings, Inc. | 1.028 |
| Liquidia Corp. | 0.7369 |
| Johnson & Johnson | 2.268 |
| Merck & Co., Inc. | -0.5405 |
| ANI Pharmaceuticals, Inc. | 1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.653M |
| Revenue (Quarterly) | 192.40M |
| Total Expenses (Quarterly) | 187.75M |
| Enterprise Value | 1.151B |
| Gross Profit Margin (Quarterly) | 69.60% |
| Profit Margin (Quarterly) | 2.42% |
| Earnings Yield | 1.37% |
| Operating Earnings Yield | 2.59% |
| Normalized Earnings Yield | 1.925 |